John F. DiPersio

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

John F. DiPersio

Dec 16, 2024, 18:20 | Insight

Nektar Therapeutics Presented Phase 2 Results for NKTR-255 at ASH 2024

Proof-of-Concept Study Highlights Improved Complete Response Rates and Durability in Relapsed/Refractory Large B-Cell Lymphoma at…

Aug 16, 2024, 11:52 | Insight

Myeloma Paper of the Day, August 16th, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: Somatic mutation phasing and haplotype…

Jul 23, 2024, 06:05 | Blog

Talha Badar: The role of allogeneic stem cell transplantation in Ph+ve ALL

Talha Badar shared on X: "The role of allogeneic stem cell transplantation in Ph+ve ALL? Outcome…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023